MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

<< Previous

Bullboard Posts

Next >>

Post by goldyhawkon Jan 18, 2022 8:59am

137 Views

Post# 34327687

MEDMIRA'S POSH ? COMPLETED ? RESULTS AVAILABLE WHEN ?

Study Design

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	1500 participants
Intervention Model:	Sequential Assignment
Masking:	None (Open Label)
Primary Purpose:	Diagnostic
Official Title:	Dual Syphilis and HIV Point of Care Testing (POCT) to Improve Access to Testing Among Inner City, Remote, Rural and Hard to Reach Populations in Alberta
Actual Study Start Date :	July 27, 2020
Estimated Primary Completion Date :	December 31, 2021
Estimated Study Completion Date :	December 31, 2021 https://clinicaltrials.gov/ct2/show/NCT04514848